no image available Dickens & Co. "Beating the Odds: A Head-to-Head Showdown in NSCLC Treatment" "Is platinum combination rechallenge therapy a viable alternative to docetaxel monotherapy in patients who've already battled platinum-based chemoradiotherapy?" Price: 23.00€